Advanced search
Publication Cover
Journal of Drug Assessment Volume 9, 2020 - Issue 1
Journal homepage
1,577
Views
2
CrossRef citations to date
0
Altmetric
Women's Health

Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?

László KardosDepartment of Infectology, University of Debrecen, Debrecen, HungaryCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4749-1057
ORCID Icon
Pages 37-42 | Received 27 Sep 2019, Accepted 29 Jan 2020, Published online: 24 Feb 2020

References

  • Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363–367.
  • Creinin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception. Obstetrics Gynecol. 2006;108(5):1089–1097.
  • Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. The Lancet. 2010;375(9714):555–562.
  • Kapp N, Abitbol JL, Mathé H, et al. Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception. Contraception. 2015;91(2):97–104.
  • Gemzell-Danielsson K, Kardos L, von Hertzen H. Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials. Curr Med Res Opin. 2015;31(12):2241–2248.
  • European Medicines Agency. Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight. 2014. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002145.jsp&mid=WC0b01ac058004d5c1
  • Jatlaoui TC, Curtis KM. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Contraception. 2016;94(6):605–611.
  • Festin MPR, Peregoudov A, Seuc A, et al. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies. Contraception. 2017;95(1):50–54.
  • Ho PC, Kwan M. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Human Reprod. 1993;8(3):389–392. 1993/03
  • Edelman AB, Cherala G, Blue SW, et al. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing. Contraception. 2016;94(1):52–57.
  • Natavio MF, Diaz OV, Wilson ML, et al. Pharmacokinetics of the levonorgestrel-only emergency contraceptive regimen among normal-weight, obese and extremely obese users: a pilot study. Contraception. 2016;94(4):418.
  • Praditpan P, Hamouie A, Basaraba CN, et al. Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index. Contraception. 2017;95(5):464–469.
  • Natavio M, Stanczyk FZ, Molins EAG, et al. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index. Contraception. 2019;99(5):306–311.
  • Westhoff CL, Torgal AH, Mayeda ER, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use. Obstetrics Gynecol. 2010;116(2, Part 1):275–283.
  • Westhoff CL, Torgal AH, Mayeda ER, et al. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010;81(6):474–480.
  • Luo D, Westhoff CL, Edelman AB, et al. Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment. Contraception. 2019;99(4):256–263.
  • Faculty of Sexual & Reproductive Healthcare (FSRH). Emergency contraception March 2017 (Updated December 2017). 2017. Available from: https://www.fsrh.org/standards-and-guidance/current-clinical-guidance/emergency-contraception/
  • American Society for Emergency Contraception (ASEC). Statement: Efficacy of emergency contraception and body weight: current understanding and recommendations. 2016. Available from: http://www.americansocietyforec.org/uploads/3/4/5/6/34568220/asec_ec_efficacy_and_weight_statement.pdf
  • Regulation TFoPMoF. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. The Lancet. 1998;352(9126):428–433.
  • von Hertzen H, Piaggio G, Peregoudov A, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. The Lancet. 2002;360(9348):1803–1810.
  • Dada OA, Godfrey EM, Piaggio G, et al. A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception. 2010;82(4):373–378.
  • StataCorp. Stata Statistical Software: Release 15. College Station (TX): StataCorp LLC; 2017.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.